search
Back to results

The Effects of Calorie Restriction With or Without Metformin on Weight and Insulin Resistance

Primary Purpose

Body Weight, Insulin Resistance

Status
Completed
Phase
Phase 4
Locations
Belgium
Study Type
Interventional
Intervention
metformin
"standard diet advice"
"personal diet advice"
Sponsored by
University Hospital, Ghent
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional treatment trial for Body Weight

Eligibility Criteria

20 Years - 55 Years (Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: 20-55 years of age Body mass index (BMI) equal to or greater than 30 kg/m² Insulin resistance as determined by oral glucose tolerance test (OGTT) and HOMA Exclusion Criteria: Diabetes mellitus, kidney insufficiency, or hepatic insufficiency Hypogonadism with other etiology than overweight Pregnancy BMI equal to or greater than 40 kg/m²

Sites / Locations

  • University Hospital Ghent

Outcomes

Primary Outcome Measures

Effect of diet on weight and insulin sensitivity/insulin resistance after 20 and 52 weeks of treatment

Secondary Outcome Measures

Effect of metformin on weight and insulin resistance after 20 and 52 weeks of treatment

Full Information

First Posted
August 23, 2005
Last Updated
December 19, 2007
Sponsor
University Hospital, Ghent
search

1. Study Identification

Unique Protocol Identification Number
NCT00134290
Brief Title
The Effects of Calorie Restriction With or Without Metformin on Weight and Insulin Resistance
Official Title
The Effects of Calorie Restriction - Whether or Not Calculated Based on BMR (Basic Metabolic Rate) - With or Without Metformin on Weight and Insulin Resistance of Obese Insulin Resistant Patients
Study Type
Interventional

2. Study Status

Record Verification Date
December 2007
Overall Recruitment Status
Completed
Study Start Date
January 2002 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
May 2004 (Actual)

3. Sponsor/Collaborators

Name of the Sponsor
University Hospital, Ghent

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
This is a study to: Determine the difference between strong hypo-energetic "standard diet advice" and modest hypo-energetic "personal diet advice"; and Determine the influence of insulin-insensitivity on obesity and weight reduction by treating patients with metformin or placebo.
Detailed Description
The aim of the present study was to determine what the difference is of a strong hypo-energetic "standard diet advice" and a modest hypo-energetic "personal diet advice" which was determined by the energy needs of a person as calculated with a combination of basal metabolic rate (BMR) and physical activity level (PAL) on weight loss and insulin sensitivity. Secondly, this study wanted to determine what the influence is of insulin-insensitivity on obesity and weight reduction by treating the patients with metformin or placebo. The subjects were therefore randomised into two double blinded groups receiving either metformin (2 x 850 mg per day) or placebo in combination with a moderate energy restriction and a exercise regimen of 30 minutes per day for 1 year. Treatment effects of both diets and the effect of metformin on weight reduction and insulin sensitivity were determined after a treatment period of 20 and 52 weeks. Insulin sensitivity was quantified using the homeostasis model assessment (HOMA) and the OGTT. Body composition was determined with the bioelectrical impedance method. Blood was also drawn for hormonal and biochemical analyses after 20 and 52 weeks of treatment. Furthermore, the patients had to fill out a 3-day food diary at baseline, after 20 weeks and after 52 weeks.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Body Weight, Insulin Resistance

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
Double
Allocation
Randomized
Enrollment
48 (false)

8. Arms, Groups, and Interventions

Intervention Type
Drug
Intervention Name(s)
metformin
Intervention Type
Behavioral
Intervention Name(s)
"standard diet advice"
Intervention Type
Behavioral
Intervention Name(s)
"personal diet advice"
Primary Outcome Measure Information:
Title
Effect of diet on weight and insulin sensitivity/insulin resistance after 20 and 52 weeks of treatment
Secondary Outcome Measure Information:
Title
Effect of metformin on weight and insulin resistance after 20 and 52 weeks of treatment

10. Eligibility

Sex
All
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
55 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: 20-55 years of age Body mass index (BMI) equal to or greater than 30 kg/m² Insulin resistance as determined by oral glucose tolerance test (OGTT) and HOMA Exclusion Criteria: Diabetes mellitus, kidney insufficiency, or hepatic insufficiency Hypogonadism with other etiology than overweight Pregnancy BMI equal to or greater than 40 kg/m²
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Mimi Giri, MD, PhD
Organizational Affiliation
University Hospital, Ghent
Official's Role
Principal Investigator
Facility Information:
Facility Name
University Hospital Ghent
City
Ghent
ZIP/Postal Code
9000
Country
Belgium

12. IPD Sharing Statement

Links:
URL
http://www.uzgent.be
Description
Website University Hospital Ghent

Learn more about this trial

The Effects of Calorie Restriction With or Without Metformin on Weight and Insulin Resistance

We'll reach out to this number within 24 hrs